// App-Quantinova.ai

166 : Long-term (156-week) improvements in dactylitis and enthesitis with apremilast inpsoriatic arthritis subjects: analysis of a large, pooled PALACE 1-3 database

Researchers

Presenter

  • Dafna D Gladman

Principal Investigators

  • Arthur Kavanaugh

  • Juan J Gomez-Reino

  • Jurgen Wollenhaupt

  • Maurizio Cutolo

  • Georg Schett

  • Eric Lespessailles

  • Angela Hu

  • Christopher J Edwards

  • Charles A Birbara

  • Philip J Mease

Medical Centers

  • Division of Gastroenterology, Mount Sinai Hospital, Toronto, Ontario, Canada

  • University of California, San Diego School of Medicine, La Jolla, CA

  • Desarmen of Rheumatology, Unit Hospital Clinico Universitario, Santiago, Spain

  • Rheumatology, Schön Klinik Hamburg Eilbek, Hamburg, GERMANY

  • Rheumatology, University of Messina, Messina, Italy

  • Rheumatology, University Erlangen-Nuremberg, Erlangen, GERMANY

  • Rheumatology, University of Orléans, Orleans, FRANCE

  • Biostatistics, Celgene Corporation, Summit, NJ, USA

  • Rheumatology, University of Southampton NHS FT, Southampton, UNITED KINGDOM

  • Medicine/Rheumatology, University of Massachusetts Medical School, Worcester, MA 01605, USA

  • Swedish Medical Center and University of Washington School of Medicine, Seattle, WA

Locations

  • Canada

  • United States

  • Spain

  • Germany

  • Italy

  • France

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Ankylosing spondylitis

  • Dactylitis

  • Inflammatory Arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Apremilast

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved